Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 288
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
After the Readout: How the Field Is Interpreting Compass’ Phase 3 Psilocybin Data
Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts
Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast
BREAKING: Second Positive Phase 3 for Compass’ Psilocybin, Though Modest Magnitude Raises Questions
AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal
Silo Pharma, Inc. Enters into an Exclusive Option Agreement with the...
MagicMed Industries Announces Collaboration with Artificial Intelligence Thought Leaders and the...
PsyBio Therapeutics Announces Retention of Market Maker
PharmaDrug Announces World-Renowned Gastric Cancer Expert Dr. Yelena Y. Janjigian Joins...
Regulatory Approvals Place Numinus Lab at the Forefront of Global Psychedelics...
MINDCURE Discovers Potential Opportunity for Ibogaine-Assisted Psychotherapy to Treat Neuropathic Pain...
atai Life Sciences Announces the Closing of its $157 Million Series...
Cybin Inc. Announces Uplisting to OTCQB Venture Market
Red Light Holland’s iMicro Digital Care App Launches Virtual Telecounseling with...
Lobe Sciences Appoints NFL Alumni Association President, Bart Oates Esq. to...
Load more